Advanced Oncotherapy (AVO) Proton Therapy Programme Progressing Well – IFA Magazine

Advanced Oncotherapy (AVO) was moving closer to success with its proton therapy for cancer treatment, updating the market on Tuesday of progress with its proton accelerator programme, dubbed ‘LIGHT’. The AIM-traded company said its proton source, which was being constructed by Pantechnik in Bayeux, France, had been fully assembled and was ready for initial testing […]

Testing underway for UK proton beam cancer treatment – Daily Telegraph

By Tara Cunningham 28 MARCH 2016 • 7:03PM Aim-listed Advanced Oncotherapy (AVO) has begun testing its groundbreaking Light machine for the UK’s first proton beam therapy centre, in what is expected to be a cancer treatment milestone when it opens by the end of next year. Proton beam therapy uses protons to pinpoint tumours more […]

Advanced Oncotherapy (AVO) – Update on development milestones

Update on development milestones   Advanced Oncotherapy plc (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, provides an update to shareholders on the continuing progress being made in the development of the Company’s novel proton accelerator, LIGHT, in the context of the milestones which were first set in November 2014 and […]

Proton beam therapy, the silver bullet for cancer? – Proactive Investors

by Josh Allsopp – Proactive Investors Radiotherapy remains the mainstay of cancer treatment, with over half of all patients undergoing radiation based treatment of some sort. There has been a great deal of coverage recently about the possibility of an ultimate cancer cure that uses the body’s own immune system to take out the killer […]

Advanced Oncotherapy (AVO) – Senior Management Appointments

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Michel Baelen has joined the Company as Head of Regulatory Affairs and Gerardo d’Auria has been appointed as a new Technical Director with immediate effect. Michel Baelen holds a Doctorate in management sciences from France and is graduated in Electrical […]

Advanced Oncotherapy (AVO) – Recent article and Speculative Buy rating from Beaufort Securities

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, yesterday made two important announcements. One being the realignment of roles and responsibilities of the Executive team, the other being a prospectively far reaching industrialisation agreement with Thales, the giant and highly prestigious French multinational technology design and manufacturing group. 1) The agreement […]

Advanced Oncotherapy (AVO) – Directorate Change

Advanced Oncotherapy plc (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that following the continued successful development of the Company’s first LIGHT system and the recent industrialisation agreement with Thales, the Board has decided to realign the roles and responsibilities of the Executive team to add additional focus to both operational […]

Advanced Oncotherapy (AVO) – Thales industrialisation agreement

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has entered into an industrialisation agreement with Thales, for its proprietary LIGHT system. This agreement with Thales provides Advanced Oncotherapy with the support needed to move from the first LIGHT system, currently being developed for use at the Company’s flagship […]